National Health Investors, Inc. (NHI)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · NHI
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Executive — Christian Maingot: The filing discloses the execution of a Change in Control Severance Agreement, which is a compensatory arrangement rather than an actual departure or appointment.
Results of Operations and Financial Condition On August 10, 2026 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended June 30, 2026. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Chief Operations Officer — Christian Maingot: The company appointed a new Chief Operations Officer with extensive senior housing experience.
to the extent such information is responsive to the disclosure requirements of
Completion of Acquisition or Disposition of Assets. As previously reported, on April 21, 2026, National Health Investors, Inc. on behalf of itself and its affiliates identified in the Agreement (collectively, the “Company”) entered into a Purchase and Sale Agreement (the “Agreement”) with NHC/OP, L.P., a Delaware limited partnership (the “Purchaser”) and a wholly owned subsidiary of National HealthCare Corporation (“NHC”), on behalf of itself and its affiliates identified in the Agreement, ea…
Todd Siefert: The company entered into a Change in Control Severance Agreement with Todd Siefert.
Results of Operations and Financial Condition On May 4, 2026 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended March 31, 2026. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Chief Financial Officer (CFO) — John L. Spaid: Mr. Spaid is retiring from his position as CFO, and Todd Siefert has been appointed to succeed him.
to the extent such information is responsive to the disclosure requirements of
Entry into a Material Definitive Agreement. On April 21, 2026 (the “Effective Date”), National Health Investors, Inc. on behalf of itself and its affiliates identified in the Agreement (collectively, the “Company”) entered into a Purchase and Sale Agreement (the “Agreement”) with NHC/OP, L.P., a Delaware limited partnership (the “Purchaser”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), on behalf of itself and its affiliates identified in the Agreement, each of whi…
of this report is incorporated by reference into this
to the extent such information is responsive to the disclosure requirements of
Other Events On March 16, 2026, National Health Investors, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with each of BMO Capital Markets Corp., BofA Securities, Inc., Cantor Fitzgerald & Co., Huntington Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., PNFP Capital Markets, Inc., Regions Securities LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo Securities, LLC, as sales agents, principals and/…
Results of Operations and Financial Condition On February 26, 2026 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
director — D. Eric Mendelsohn: Mr. Mendelsohn resigned as a director to align with the Company's newly declassified board structure.
The company entered into new Change in Control Severance Agreements with its named executive officers.
Director — Robert G. Adams, Charlotte A. Swafford: Directors Robert G. Adams and Charlotte A. Swafford are retiring from the Board of Directors.
Results of Operations and Financial Condition On November 6, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended September 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Entry Into a Material Definitive Agreement. On September 26, 2025, National Health Investors, Inc. (the “Company”) completed an underwritten public offering of $350,000,000 aggregate principal amount of its 5.350% Senior Notes due 2033 (the “Notes”), which are fully and unconditionally guaranteed by the Guarantors (as defined below). The terms of the Notes are governed by a base indenture, dated as of January 26, 2021, by and between the Company, as issuer, and Regions Bank, as trustee (the “…
The Notes and the guarantees are general senior unsecured obligations of the Company and each Guarantor, respectively, and rank equally in right of payment with all of such entities’ existing and future senior unsecured, unsubordinated indebtedness. The notes and the guarantees, however, are effectively subordinated to all of the Company’s and each Guarantor’s existing and future secured indebtedness, respectively (to the extent of the value of the collateral securing such indebtedness). The…
Results of Operations and Financial Condition On August 6, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended June 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Results of Operations and Financial Condition. On May 5, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended March 31, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Director — Robert W. Chapin, Jr.: Appointment of Robert W. Chapin, Jr. as a new director to the Board.
Results of Operations and Financial Condition. On February 25, 2025 , National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2024. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Director — Robert T. Webb: Mr. Webb resigned from his position as a member of the Board of Directors due to retirement.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.